June 10, 2015
A Florida federal judge on Tuesday threw out a libel suit brought by Ranbaxy Laboratories Inc., ruling that medical publisher First Databank Inc. didn't incorrectly list substitutes for the acne medication Absorica in a drug database.
July 18, 2013
Ranbaxy Laboratories Inc. hit drug information publisher First Databank Inc. with a trade libel suit in Florida federal court Wednesday, saying FDB's database falsely indicates that Ranbaxy's Absorica acne drug can be safely substituted with certain other drugs, causing it more than $15 million in damages.